Sugi Predict

Sugi Predict / Compounds / SCHEMBL730051

SCHEMBL730051

SCHEMBL730051

CCOC(=O)c1c(S)n(C2CC2)c2c(OC(F)F)c(N3CCC(C(C)(C)N)C3)c(F)cc2c1=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 5/20 0.39
▸ PIM1 P11309 1/20 0.36
▸ GSK3A P49840 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ PIM3 Q86V86 1/20 0.36
▸ CSNK1G1 Q9HCP0 1/20 0.36
▸ POLB P06746 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ PRKD3 O94806 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ OPRM1 P35372 1/20 0.34
▸ CLK2 P49760 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CLK4 Q9HAZ1 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730050 1.00 KCNH2 (0.39) KCNH2PIM1GSK3AGSK3BPIM3
SCHEMBL728232 0.92 KCNH2 (0.46) KCNH2POLBKDM4EPRKD3ALDH1A1
SCHEMBL728233 0.92 KCNH2 (0.46) KCNH2POLBKDM4EPRKD3ALDH1A1
SCHEMBL727962 0.90 KCNH2 (0.38) KCNH2PIM1GSK3AGSK3BPIM3
SCHEMBL727961 0.90 KCNH2 (0.38) KCNH2PIM1GSK3AGSK3BPIM3
SCHEMBL537485 0.85 KCNH2 (0.37) KCNH2POLBKDM4EPRKD3ALDH1A1
SCHEMBL4294692 0.82 ADRB2 (0.39) KCNH2KDM4EALDH1A1HPGDALOX15
SCHEMBL729608 0.81 KCNH2 (0.45) KCNH2POLBKDM4EPRKD3ALDH1A1
SCHEMBL729609 0.81 KCNH2 (0.45) KCNH2POLBKDM4EPRKD3ALDH1A1
SCHEMBL728211 0.81 KCNH2 (0.60) KCNH2POLBKDM4EPRKD3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138346-B2 Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones ACHILLION PHARMACEUTICALS, INC. (US) 2012-03-20 — — US disclosed
US-20110213152-A1 METHOD FOR SYNTHESIS OF 8-ALKOXY-9H-ISOTHIAZOLO[5,4-B]QUINOLINE-3,4-DIONES ACHILLION PHARMACEUTICALS, INC. (US) 2011-09-01 — — US disclosed
US-7902365-B2 Using a 2-sulfone, 3-carboxylate, 4-oxoquinoline as chemical intermediate ; cyclization ACHILLION PHARMACEUTICALS, INC. (US) 2011-03-08 — — US disclosed
US-20080071086-A1 METHOD FOR SYNTHESIS OF 8-ALKOXY-9H-ISOTHIAZOLO[5,4-B]QUINOLINE-3,4-DIONES ACHILLION PHARMACEUTICALS, INC. (US) 2008-03-20 — — US disclosed
WO-2008021491-A2 METHOD FOR SYNTHESIS OF 8-ALKOXY-9H-ISOTHIAZOLO[5,4-B]QUINOLINE-3,4-DIONES ACHILLION PHARMACEUTICALS, INC. (US) 2008-02-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110213152-A1 METHOD FOR SYNTHESIS OF 8-ALKOXY-9H-ISOTHIAZOLO[5,4-B]QUINOLINE-3,4-DIONES QDPR, CYP4B1, DRD4 KCNH2 76/4885PIM1 1527/4885GSK3A 4029/4885
US-20080071086-A1 METHOD FOR SYNTHESIS OF 8-ALKOXY-9H-ISOTHIAZOLO[5,4-B]QUINOLINE-3,4-DIONES QDPR, CYP4B1, DRD4 KCNH2 76/4885PIM1 1527/4885GSK3A 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.